Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Gibb

Showing results (51-60 of 134) with videos related to

Pageof 14
Sort By:
Brain Research|August 31, 1979
Reciprocal modulation of tyrosine hydroxylasea activity in rat carotid bodyC Gonzalez, Y Kwok, J W Gibb, et al.
European Journal of Pharmacology|December 7, 1995
Body temperature effect on methylenedioxymethamphetamine-induced acute decrease in tryptophan hydroxylase activityS Che, M Johnson, G R Hanson, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 22, 1974
Proceedings: Adrenal medulla: labelling of chromaffin granules with 35-S-sulfateH Baumgartner, J W Gibb, S R Snider, et al.
Brain Research|July 22, 1982
Altered neurochemical parameters in the brains of mice (Frings) susceptible to audiogenic seizuresC Bakhit, A K Shenoy, E A Swinyard, et al.
European Journal of Pharmacology|February 14, 1991
Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in neurotensin and dynorphin A systemsM Johnson, L G Bush, J W Gibb, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1987
Effect of methamphetamine on neurotensin concentrations in rat brain regionsA A Letter, K Merchant, J W Gibb, et al.
European Journal of Pharmacology|February 10, 1987
A comparison of the neurotoxic potential of methylenedioxyamphetamine (MDA) and its N-methylated and N-ethylated derivativesD M Stone, M Johnson, G R Hanson, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1988
Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamineD M Stone, M Johnson, G R Hanson, et al.
Advances in Pharmacology (San Diego, Calif.)|November 5, 1997
Psychostimulants and neuropeptide responseG R Hanson, J D Wagstaff, K Merchant, et al.
Biochemical Pharmacology|August 17, 1993
Effects of ritanserin on the 3,4-methylenedioxymethamphetamine-induced decrease in striatal serotonin concentration and on the increase in striatal neurotensin and dynorphin A concentrationsM Johnson, L G Bush, G R Hanson, et al.
Pageof 14

Showing results (51-60 of 134) with videos related to

Sort By:
Pageof 14
Brain Research|August 31, 1979
Reciprocal modulation of tyrosine hydroxylasea activity in rat carotid bodyC Gonzalez, Y Kwok, J W Gibb, et al.
European Journal of Pharmacology|December 7, 1995
Body temperature effect on methylenedioxymethamphetamine-induced acute decrease in tryptophan hydroxylase activityS Che, M Johnson, G R Hanson, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 22, 1974
Proceedings: Adrenal medulla: labelling of chromaffin granules with 35-S-sulfateH Baumgartner, J W Gibb, S R Snider, et al.
Brain Research|July 22, 1982
Altered neurochemical parameters in the brains of mice (Frings) susceptible to audiogenic seizuresC Bakhit, A K Shenoy, E A Swinyard, et al.
European Journal of Pharmacology|February 14, 1991
Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in neurotensin and dynorphin A systemsM Johnson, L G Bush, J W Gibb, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1987
Effect of methamphetamine on neurotensin concentrations in rat brain regionsA A Letter, K Merchant, J W Gibb, et al.
European Journal of Pharmacology|February 10, 1987
A comparison of the neurotoxic potential of methylenedioxyamphetamine (MDA) and its N-methylated and N-ethylated derivativesD M Stone, M Johnson, G R Hanson, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1988
Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamineD M Stone, M Johnson, G R Hanson, et al.
Advances in Pharmacology (San Diego, Calif.)|November 5, 1997
Psychostimulants and neuropeptide responseG R Hanson, J D Wagstaff, K Merchant, et al.
Biochemical Pharmacology|August 17, 1993
Effects of ritanserin on the 3,4-methylenedioxymethamphetamine-induced decrease in striatal serotonin concentration and on the increase in striatal neurotensin and dynorphin A concentrationsM Johnson, L G Bush, G R Hanson, et al.
Pageof 14